home / stock / lucd / lucd quote
Last: | $0.905 |
---|---|
Change Percent: | 0.0% |
Open: | $0.89 |
Close: | $0.905 |
High: | $0.9338 |
Low: | $0.88 |
Volume: | 85,206 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.905 | $0.89 | $0.905 | $0.9338 | $0.88 | 85,206 | 05-17-2024 |
$0.89 | $0.89 | $0.89 | $0.92 | $0.876351 | 90,799 | 05-16-2024 |
$0.8989 | $0.95 | $0.8989 | $0.9678 | $0.89 | 147,472 | 05-15-2024 |
$0.9287 | $1 | $0.9287 | $1 | $0.92 | 220,062 | 05-14-2024 |
$0.95 | $0.95 | $0.95 | $0.9602 | $0.915 | 126,032 | 05-13-2024 |
$0.9444 | $0.9908 | $0.9444 | $0.9999 | $0.92 | 247,573 | 05-10-2024 |
$0.9297 | $0.96 | $0.9297 | $0.9781 | $0.91 | 302,849 | 05-09-2024 |
$0.95 | $1 | $0.95 | $1.04 | $0.95 | 276,546 | 05-08-2024 |
$1.03 | $1.06 | $1.03 | $1.11 | $1.0101 | 418,341 | 05-07-2024 |
$1.04 | $0.96 | $1.04 | $1.07 | $0.94 | 475,964 | 05-06-2024 |
$0.9297 | $0.91 | $0.9297 | $0.9869 | $0.8427 | 283,037 | 05-03-2024 |
$0.95 | $0.9 | $0.95 | $0.99 | $0.87 | 540,942 | 05-02-2024 |
$0.8787 | $0.87 | $0.8787 | $0.919999 | $0.86 | 109,485 | 05-01-2024 |
$0.901 | $0.789 | $0.901 | $0.94 | $0.7467 | 666,654 | 04-30-2024 |
$0.7507 | $0.69 | $0.7507 | $0.7599 | $0.68 | 276,737 | 04-29-2024 |
$0.6831 | $0.6777 | $0.6831 | $0.6999 | $0.664 | 123,806 | 04-26-2024 |
$0.6701 | $0.68 | $0.6701 | $0.68 | $0.6301 | 236,194 | 04-25-2024 |
$0.6831 | $0.73 | $0.6831 | $0.73 | $0.6749 | 234,871 | 04-24-2024 |
$0.723 | $0.769 | $0.723 | $0.78 | $0.701101 | 269,450 | 04-23-2024 |
$0.7508 | $0.8173 | $0.7508 | $0.8173 | $0.7397 | 173,753 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Inc. Company Name:
LUCD Stock Symbol:
NASDAQ Market:
PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire Lucid strengthens balance sheet and secures a July 17, 2024 MolDX pre-submission meeting date Veris Health completes MOU with The Ohio State's James Cancer Hospital Con...
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PR Newswire Quarterly EsoGuard ® test volume increased 10 percent Strengthened balance sheet following completion of $29.8 million Series B Preferred Stock Offering ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...